sponsored links

Bone Drug Reduces Odds for Breast Cancer’s Return: Study (HealthDay)

Sponsored Links

HealthDay – FRIDAY, June 3 (HealthDay News) — Early stage breast cancer patients can see their chances of the cancer’s return drop by 32 percent when the osteoporosis drug Zometa is added to regular hormone therapy for three years after surgery, Austrian researchers report.

View full post on Yahoo! News: Health News


Sponsored Links
You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.

AddThis Social Bookmark Button

Leave a Reply

You must be logged in to post a comment.